The risk of colorectal cancer in ulcerative colitis: a meta-analysis
- PMID: 11247898
- PMCID: PMC1728259
- DOI: 10.1136/gut.48.4.526
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
Abstract
Background and aims: Controversy surrounds the risk of colorectal cancer (CRC) in ulcerative colitis (UC). Many studies have investigated this risk and reported widely varying rates.
Methods: A literature search using Medline with the explosion of references identified 194 studies. Of these, 116 met our inclusion criteria from which the number of patients and cancers detected could be extracted. Overall pooled estimates, with 95% confidence intervals (CI), of cancer prevalence and incidence were obtained using a random effects model on either the log odds or log incidence scale, as appropriate.
Results: The overall prevalence of CRC in any UC patient, based on 116 studies, was estimated to be 3.7% (95% CI 3.2-4.2%). Of the 116 studies, 41 reported colitis duration. From these the overall incidence rate was 3/1000 person years duration (pyd), (95% CI 2/1000 to 4/1000). The overall incidence rate for any child was 6/1000 pyd (95% CI 3/1000 to 13/1000). Of the 41 studies, 19 reported results stratified into 10 year intervals of disease duration. For the first 10 years the incidence rate was 2/1000 pyd (95% CI 1/1000 to 2/1000), for the second decade the incidence rate was estimated to be 7/1000 pyd (95% CI 4/1000 to 12/1000), and in the third decade the incidence rate was 12/1000 pyd (95% CI 7/1000 to 19/1000). These incidence rates corresponded to cumulative probabilities of 2% by 10 years, 8% by 20 years, and 18% by 30 years. The worldwide cancer incidence rates varied geographically, being 5/1000 pyd in the USA, 4/1000 pyd in the UK, and 2/1000 pyd in Scandinavia and other countries. Over time the cancer risk has increased since 1955 but this finding was not significant (p=0.8).
Conclusions: Using new meta-analysis techniques we determined the risk of CRC in UC by decade of disease and defined the risk in pancolitics and children. We found a non-significant increase in risk over time and estimated how risk varies with geography.
Figures



Similar articles
-
Risk of colorectal cancer in ulcerative colitis in India.J Gastroenterol Hepatol. 2005 May;20(5):705-9. doi: 10.1111/j.1440-1746.2005.03810.x. J Gastroenterol Hepatol. 2005. PMID: 15853982
-
Colorectal cancer and dysplasia risk of ulcerative colitis patients in a tertiary referral center in Turkey.Turk J Gastroenterol. 2019 Feb;30(2):139-147. doi: 10.5152/tjg.2018.18221. Turk J Gastroenterol. 2019. PMID: 30460897 Free PMC article.
-
[Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].Orv Hetil. 2006 Jan 29;147(4):175-81. Orv Hetil. 2006. PMID: 16515026 Hungarian.
-
Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis.Aliment Pharmacol Ther. 2007 Mar 15;25(6):657-68. doi: 10.1111/j.1365-2036.2007.03241.x. Aliment Pharmacol Ther. 2007. PMID: 17311598 Review.
-
Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis.Gastroenterol Clin North Am. 2006 Sep;35(3):517-31. doi: 10.1016/j.gtc.2006.07.005. Gastroenterol Clin North Am. 2006. PMID: 16952738 Review.
Cited by
-
Future of Endoscopy in Inflammatory Bowel Diseases (IBDs).Cureus. 2022 Sep 25;14(9):e29567. doi: 10.7759/cureus.29567. eCollection 2022 Sep. Cureus. 2022. PMID: 36312686 Free PMC article. Review.
-
Non-cell autonomous effects of targeting inducible PGE2 synthesis during inflammation-associated colon carcinogenesis.Carcinogenesis. 2015 Apr;36(4):478-86. doi: 10.1093/carcin/bgv004. Epub 2015 Jan 29. Carcinogenesis. 2015. PMID: 25634334 Free PMC article.
-
Immunohistochemical analysis of the DNA methyltransferase 3b expression is associated with significant improvements in the discrimination of ulcerative colitis-associated neoplastic lesions.Surg Today. 2013 Nov;43(11):1275-80. doi: 10.1007/s00595-012-0456-6. Epub 2013 Jan 10. Surg Today. 2013. PMID: 23307264
-
Glycoprotein A33 deficiency: a new mouse model of impaired intestinal epithelial barrier function and inflammatory disease.Dis Model Mech. 2015 Aug 1;8(8):805-15. doi: 10.1242/dmm.019935. Epub 2015 May 8. Dis Model Mech. 2015. PMID: 26035389 Free PMC article.
-
Parthenolide induces apoptosis in colitis-associated colon cancer, inhibiting NF-κB signaling.Oncol Lett. 2015 May;9(5):2135-2142. doi: 10.3892/ol.2015.3017. Epub 2015 Mar 6. Oncol Lett. 2015. PMID: 26137027 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous